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It  has  been definitely established that  Type I antipneumococcus 
sera is an effective bactericidal agent when administered intravenously 
to human beings in adequate dosage.  In addition there is considerable 
accumulated evidence to suggest the value of such sera in non-bac- 
teremic cases of Type I pneumococcus lobar pneumonia treated early 
in the disease.  Despite these facts, Type I antiserum has not become 
a widely  used therapeutic agent in the hands of the general practitioner. 
Besides the expense incident to the use of large quantities of serum, 
is the fact that in general practice the physician hesitates to admin- 
ister any medication intravenously, usually reserving such treatment 
for hospitalized cases, on account of the perhaps unwarranted fear of 
reactions from serum sensitivity or  from such  remote accident as 
thrombosis  or  embolism.  It  was  therefore  thought  expedient  to 
determine whether adequate doses of various preparations of Type I 
antipneumococcus serum administered by  the  intramuscular route 
were as efficient in their bactericidal and therapeutic effects as similar 
doses given intravenously. 
In this connection it is worthy to note that the intravenous route of 
serum administration seemed to have been established by the work of 
Neufeld and Handel  1 as the only satisfactory means of introducing 
this therapeutic agent.  Apart from the work of Cecil and Baldwin  2 
with subcutaneous injection of Huntoon's antibody there does not 
seem to have been any attempt made to determine by actual com- 
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parison,  the superiority of this less convenient route of therapy either 
on experimental  animals or human  beings suffering from the disease. 
This  communication  proposes  to  submit  evidence  based  on  a  com- 
parison  of  the  intramuscular  and  intravenous  routes  of  treatment 
of an  experimental  pneumococcus infection  in  the  rabbit. 
Methods 
An attempt was made to produce as nearly as possible a  constant "standard" 
infection in the rabbit by the intradermal injection of a standard dose of 18 hour 
Type I  pneumococcus broth culture after the method of Goodner?  This  acute 
infection which Goodner names "dermal pneumonia" and believes to resemble in 
many respects the picture of pneumococcus pneumonia in human beings, was then 
treated by the administration of equal quantities of different serum preparations 
given by the intravenous and intramuscular routes respectively, at different times 
after infection with culture. 
In each individual experiment the size of dose and the time of treatment were 
fixed, the only variable being the route of administration.  Moreover, a number of 
experiments were performed in which the size of the dose and the time of treatment 
were varied.  It was felt that an analysis based on such a  method of collecting 
data would tend to properly allocate the chance probability of biological variation 
of the experimental animal, a probability that might be iargely operative in pro- 
ducing  favorable  or  unfavorable  results  if  only single  experiments,  even  with 
large groups of animals, were performed. 
Technique 
In each experiment 0.1 cc. of a 1 : 100 dilution of an 18 hour blood broth culture 
of Type I  pneumococcus was injected intradermally  to one side of the ventral 
midline of each rabbit weighing from 1800 to 2200 gm.  At a given period after 
infection,  the animals were divided into two equal batches and  treated  with a 
certain dose of serum by the intravenous and intramuscular  routes,  the former 
receiving the dose in the marginal ear vein,  the latter  deep in the leg muscles 
immediately  adjacent  to  the  gluteal  region.  A  control untreated  animal  was 
always included in each experiment to establish the untreated course of the disease 
for the rabbit.  In each experiment a batch of white mice weighing from 18 to 22 
gin., were injected intraperitoneaUy with suitable dilutions of the culture, on which 
blood plates were poured and the number of organisms estimated, so as to establish 
the full virulence of the culture for mice, as well as to permit of comparison of one 
set of experiments with another in respect to variations as to virulence and total 
bacterial content of the infecting culture. 
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In order to compare the bactericidal effects  of the serum by the different routes, 
blood cultures were taken from the marginal veins just prior to administration of 
serum and at varying intervals thereafter.  It was thus possible to study in each 
animal the initial height of the bacteremia, the height following  treatment, and in 
many cases in which cultures were taken at frequent intervals after treatment, 
the rate of sterilization of blood by the different  routes of treatment. 
As a rule, either seven or eleven rabbits were used in an individual experiment, 
one being a control untreated animal, the remaining animals being divided into 
two  equal groups and  treated  by  the  intravenous and  intramuscular  routes 
respectively. 
The  results  of  these  experiments  will  be  reported  according to: 
(a)  the  time  that  elapsed  between infection and  administration  of 
serum  and  (b)  the  size of  the  therapeutic  dose  at  that given  time 
interval. 
Before analyzing the results of the various experiments, only animals 
that had survived the intradermal injection for a  10 day period, after 
injection,  were  included  as  survivals.  This  time  interval  places  a 
rigid control on our figures, as in tests of a  similar nature in which 
highly susceptible animals are infected with virulent cultures of the 
pneumococcus, e.g. the mouse protection test, the time of expiration 
of the test has been arbitrarily fixed at a  much shorter time interval 
(the mouse protection test covers a period of 5 days). 
Similarly in order to  exclude, as much as  possible,  animals dying 
from  causes  other  than  pneumococcus  infection,  only  those  dying 
within 10 days and showing on autopsy, pneumococci in either culture 
of the heart's blood or the local lesion or of the brain, were included 
in the analysis of the results, those dying with negative cultures being 
discarded entirely from the series. 
The present analysis is then based on a study of 181 rabbits treated 
at different times with different doses of various serum preparations 
by the intravenous and intramuscular routes. 
Animals Treated at 24 Hour Interval 
In this group several dose levels were investigated, the dose ranging 
from 400  units*  to  2500  units.  In  those experiments in  which the 
smaller doses (e,g. 400 units and 800 units) were used,  the death rate 
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following treatment  was  high,  irrespective of  the  route  of adminis- 
tration or the nature of the therapeutic agent. 
For example, in the 400 unit group, a serum prepared by the use of 
pneumococcus exudate as antigen  ~ (Foundation Preparation  15), was 
compared with  one prepared by the standard  method of immuniza- 
tion with formalinized pneumococcus vaccine (Standard Preparation 
14)  (Table I). 
From Table  I  it is evident that the doses used were subeffective, 
there being a  relatively low survival rate for each preparation. 
TABLE  I 
400  units at 24 hour interval 
Foundation Preparation  15.. 
Standard Preparation  14. 
Intravenous  Intramuscular 
No. of  Sur-  No. of  Sur- 
animals  vived  animals  vived 
7  1  7  2 
6  0  6  0 
Total 
surviving 
intravenous 
dosage 
~r c~ 
14 
0 
Total 
surviving 
intra- 
muscular 
dosage 
per cent 
29 
0 
TABLE  II 
800  units  at  24 hour interval 
Intravenous  Intramuscular 
Foundation Preparation 15 ......... 
Standard Preparation 14 ........... 
Felton's Antibody 52 .............. 
No. of I  Sur- 
at "reals  ~'~ed 
9  3 
No. of [  Sur- 
a~ "rnals  w'~ed 
9  1 
Total 
surviving 
intravenous 
dosage 
per cent 
22 
33 
50 
Total 
surviving 
iutra- 
muscular 
dosage 
pet cent 
38 
11 
25 
In  the  case  of  those  animals  receiving  800  units  (Table  II),  it  is 
seen that the survival rate rises for both the "exudate" and the "vac- 
cine"  sera,  the percentage  of survivals still suggesting a  subeffective 
zone of therapy,  however.  It is of interest  to note that the survival 
rate  of  the  animals  receiving  Felton's  antibody  intravenously  was 
higher  than  either  of  the  unrefined  sera  administered  by  the  same 
Curphey, T. J., and Baruch, H. B., Proc. Soc. Exp. Biol. and Med., 1929, 26, 
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route, whereas the survival rate on the intramuscular dosage of this 
preparation, was definitely lower than that of the exudate antiserum 
(Preparation 15) but higher again than that of the vaccine antiserum 
(Preparation  14).  Whether this  can be  interpreted  as  evidence in 
favor  of  the  greater  therapeutic  effect of  exudate  antisera  admin- 
istered intramuscularly is open to question, as the number of animals 
in this group is obviously too small to warrant any such conclusion 
being drawn. 
With the use of larger doses  of  serum,  e.g.  2500  units,  it is  seen 
from Table III that such a  dose lies in the effective zone of therapy, 
the intravenous administration of both preparations causing relatively 
high survival rates.  On the other hand the animals obtaining treat- 
TABLE IH 
2500  units at  24 hour interval 
Foundation Preparation 15. 
~tandard Preparation 15. 
Intravenous 
No.  of  Sur- 
animals vived 
15  10 
5  4 
Intramuscular 
No. of  Sur- 
animals  rived 
11  5 
6  2 
Total  Total 
survlving  surviving 
intra-  intravenous 
dosage  muscular 
dosage 
~er cent  per cont 
66  46 
80  33 
ment by the intramuscular route on  the  standard  serum showed a 
lower survival rate than did those on the exudate antiserum, a  fact 
which also appeared evident at both the previous dose levels of 800 
and 400 units respectively.  Moreover, from a  comparison of Tables 
I to III, it is seen that in the case of the standard unrefined antiserum, 
there appears to be a proportionate relationship between the increase 
in the survival rates by either route of treatment and the number of 
units  of serum administered.  In  the  case  of this  preparation,  the 
number of animals surviving after the intramuscular dosage is from 
one-half to one-third less than those receiving serum intravenously. 
On the other hand, there is a much wider disparity evident when the 
results of the intramuscular dosage of the exudate antiserum are con- 
sidered, for while the survivals on the intravenous dosage with this 
preparation are in proportion  to  the increase in the unit size of the 
dose,  the survivals on the intramuscular dosage at the 400  and 800 930  TYPE  I  PNEUMOCOCCUS  ANTISERA 
unit levels are actually greater in  both  instances than  those in  the 
intravenous group, a  fact in distinct contrast to the observations on 
the standard sera.  One might easily infer from this that the thera- 
peutic effects of the exudate antisera when administered intramuscu- 
larly,  bear  little  proportional  relationship  to  the  number  of  anti- 
bacterial units administered. 
A further inference that is perhaps not unwarranted on the face of the 
collected data would be that the intramuscular route of dosage repre- 
sents the more favorable method of injecting exudate antisera. 
The Relationship  between the Roule  of Dosage and  the Degree of 
Bacteremia 
It seemed important to know what relationship existed between the 
route of serum dosage and the extent of bacterial invasion of the blood 
at  the  time  of  administration  of  the  serum.  In  Tables  I  to  III 
where an analysis was based on the size of the dose administered, no 
account was  taken of the height of the bacteremic level in  the in- 
dividual  animal  at  the  time of treatment.  It  is  obvious  that  this 
factor must be considered in order to correctly evaluate the value of 
intramuscular serum dosage,  as  in  the rabbit  there is  a  very wide 
variation in the individual response to a standard dose of pneumococci 
(Type I) injected intradermally in so far as the number of organisms 
present in  the blood at  the end of a  given period after infection is 
concerned.  That  this  variation  in  individual  animals  to  bacterial 
invasion has its counterpart in human beings, is beyond doubt.  In 
order,  then  to  determine the effect of intramuscular dosage,  it  ap- 
peared necessary to compare the effect of such dosage with the intra- 
venous route in a group of animals having the same relative bacteremic 
level at  the time of treatment.  For purposes of comparison,  three 
arbitrary levels were chosen representing for the rabbit, cases of mild, 
moderately severe and severe blood invasion.  The results of several 
experiments were studied collectively, at two fixed dose levels, i.e. 800 
units and 2500 units, the animals being divided into the three bactere- 
mic groups (Tables IV and V). 
Unfortunately, with such a  division, the number of animals falling 
in each bacteremic group is small, and while this considerably vitiates 
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relationship between the outcome of the infection and the height of 
the bacteremia, being more dependent on the latter than on the route 
of dosage.  This is especially true in the case of Felton's antibody at 
the  lower dose  level  (800  units).  The  apparent  irregularities  seen 
at the higher dose level  (2500  units)  in which, in the case of Prep- 
aration 14,  there is actually a  higher survival rate on intramuscular 
dosage at the moderate bacteremic level than at the mild bacteremic 
TABLE  IV 
800 unit dosage at 24 hour interval 
Intravenous  Intramuscular 
No. of  Sur-  No. of  Sur- 
animals  rived  animals  rived 
Total 
surviving 
intravenous 
dosage 
Total 
sUrvivlI~ 
intra- 
muscular 
dosage 
(a)  Mild bacteremic level (up  to  1000 colonies per cc.) 
~er cent  per ¢enl 
Foundation Preparation 15 .........  0  0  0  0 
Standard Preparation 14 ...........  2  1  --  --  50  -- 
Felton's antibody .................  3  3  2  1  100  50 
(b)  Moderate bacteremic level (up to 100,000 colonies per cc.) 
Foundation Preparation 15 .........  2  1  3  2  50  66 
Standard Preparation 14 ...........  2  1  1  0  50  0 
Felton's antibody .................  5  3  4  2  60  50 
(c)  Severe  bacteremic  level  (over  100,000  colonies per  cc.) 
Foundation Preparation 15 .........  3  0  2  [  0  0  0 
Standard Preparation 14 ...........  1  0  5  [  0  0  0 
Felton's antibody .................  3  1  3  0  33  0 
level, might be taken as due partly to the small number of animals 
falling in each group and party to the adequacy of the larger dose in 
dealing with the higher bacteremic levels.  However, the figures do 
show that the survival rate in the animals treated intramuscularly is 
as great as in those treated by the intravenous route with Preparation 
15, 2500 units at the mild bacteremic level and 800 units at the mod- 
erate bacteremic level. 
In order to compare the efficacy of intramuscular dosage with that 932  TYPE  I  PNEUMOCOCCUS  ANTISERA 
of intravenous dosage, an analysis was made of 83 rabbits that had had 
blood  cultures  taken  at  the  time  of  treatment,  the  animals  being 
divided into groups on the basis  of blood stream invasion into those 
with mild, moderate and severe bacteremias, irrespective of the amount 
of serum administered,  the comparison being dependent on route of 
dosage  and  height  of  bacterial  invasion  at  the  time  of  treatment. 
TABLE  V 
24 hour treatment,  2500 unit dosage 
Intravenous  Intramuscular  Total 
$urvlvmg 
[ intravenous  No. of  Sur-  No. of  Sur-  ,  dosage  animals  vived  animals  vived J 
Total 
surviving 
intra- 
muscular 
dosage 
(a)  Mild  bacteremic  level 
c~t  t~cr ce~ 
Foundation Preparation  15 .........  7  5  5  4  71  80 
Standard Preparation  14 ...........  2  2  1  0  100  0 
(b)  Moderate  bacteremie  level 
Foundation Preparation  15 .........  [  2  [  2  3  [  1  100  33 
Standard Preparation  14 ...........  [  1  [  1  2  [  1  100  50 
•  (c)  Severe  bacteremic  level 
Foundation Preparation  15 ........  i  6  3  3  0  50  0 
Standard Preparation  14 ..........  2  1  3  1  50  33 
(d)  Bacteremic levels up to 100,000 colonies per cc.; i.e., (a) "b (b) 
Foundation Preparation  15 ........  9  7  8  ]  5  78  63 
Standard Preparation  14 ..........  i  3  3  3  [  1  100  33 
Table  VI  shows  the  results  of  such  a  comparison.  Thus  in  the 
animals with mild blood invasion, the survival rates for Preparation 
15 and Felton's antibody show that intramuscular dosage in the case 
of the former is  as efficient and in  the case of the latter nearly as 
efficient as intravenous dosage.  In the group with moderate blood 
invasion the Felton's antibody given intramuscularly is as efficient as 
the  intravenous  dose,  while  Preparation  15  on  the  other  hand,  is 
Slightly less efficient when given intramuscularly.  The figures in the THEODORE  J.  CURPHEY  AND  HERMAN  B.  BARUCH 
TABLE  VI 
933 
Intravenous  Intramuscular 
No. of  Sur-  No. of  $ur- 
animals  vlved  animals vlved 
Total 
surviving 
intravenous 
dosage 
Total 
surviving 
intra- 
muscular 
dosage 
(a) Mild bacteremic levels 
Foundation  Preparation  15 .........  7  5  5  4  71  80 
Standard  Preparation14 ...........  I  4  I  3  I  --  I  --  I  75  -- 
(b) Moderate bacteremic levels 
Foundation Preparation  15 .........  4  3  6  3 
Standard  Preparationl4 ...........  [  3  I  2  I  3  I  1  I 
Felton's antibody .................  6  3  5  3 
75  50 
66  33 
50  60 
(c) Severe  bacteremias 
Foundation Preparation  15 .........  ]  9  3  [  5  0 
Standard  Preparation  14 ...........  I  3  I  1  ]  7  [  1  ] 
1161  i 
33  0 
33  14 
25  0 
The above analysis is based purely on the height of bacteremic level at time of 
treatment, irrespective of size of dose of serum used in treatment. 
TABLE  VII 
200 units at 6 hour interval 
Intravenous  Intramuscular  Total  Total 
surviving  surviving  intra- 
No. of  Sur-  No. of  Sur-  intravenous muscular 
animals rived  animals rived  dosage  dosage 
~er cent  p~r ten| 
Preparation  15.  7  4  9  1  56  11 
group with severe blood stream invasion show that  little  can be ex- 
pected by intramuscular administration.  They also show, however, a 
low survival rate on intravenous administration, and this, despite the 934  TYPE  I  PNEUMOCOCCUS  ANTISERA 
fact that many animals in this group  were  treated with large  doses 
of serum.  This would seem to agree with the clinical experience in the 
case of overwhelming bacteremias complicating the local lesion, where, 
irrespective of the  total  amount of serum given intravenously,  the 
therapeutic result is uniformly poor. 
Animals Treated at 6 Hour Interval 
While most of the experiments were performed at the longer  time 
interval, data were collected on 57 rabbits treated with different doses 
of serum between 6 to 8 hours after the standard intradermal infection. 
Table VII shows  the comparison  between intravenous and  intra- 
muscular dosage with a subeffecfive dose (200 units) of Preparation 15. 
TABLE  VIII 
400 units at 6 hour interval 
Foundation Preparation 15. 
Foundation Preparation 2375/11 .... 
~tandard Preparation 14. 
]tandard Preparation 8. 
Total. 
Intravenous 
No. of  Sur- 
rabbits  vived 
3  !  2 
3  i  1 
11  5 
4  2 
21  11o 
Intramuscular 
No. of  Sur- 
rabbits  vived 
4  2 
4  2 
9  6 
3  2 
20  12 
Total 
surviving 
intravenous 
dosage 
~£r c~t 
67 
33 
46 
5O 
48 
Total 
surviving 
intra- 
muscular 
dosage 
percent 
5O 
5O 
67 
67 
60 
The ineffectiveness of such a  dose administered intramuscularly is 
striking.  This is undoubtedly due to the diminished concentration of 
bactericidal antibody in the blood, the result of slower absorption by 
the intramuscular route.  That the effect is not entirely dependent on 
the rate of absorption,  however, will be shown later in  the case of 
effective doses of serum. 
If a larger unit dosage (400 units) in the subeffective zone of therapy 
be used, it  is seen from Table VIII that the survival rate following 
intramuscular dosage rises.  Similarly if the survival rate of this group 
is considered regardless of the preparation used, but wholly on a com- 
parison of the route of therapy, it is seen that the survival rate on the 
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(60 per cent)  than that of the same preparations  on the  intravenous 
dosage (48 per cent).  There thus appears to be sufficient evidence in 
favor of the therapeutic value of pneumococcus antisera  given by the 
intramuscular route. 
The Bactericidal Effect of Intramuscular Doses of Serum 
An  attempt  was made  to  compare  the  sterilizing  effect of  similar 
doses of the same antiserum given by the intravenous and  the intra- 
lO0~OOqO00 
10,000000 
.~  ~,o~ooo 
"5- 
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0- 
I  to,~ 
'b-- 
1~oo 
100 
O0  24  ~'/  30  48 
Hours afte~ in~ectton 
Tv.xT-FIo. 1.  The bacteremic level of animals treated  with 800 units of anti- 
serum by the intramuscular and intravenous routes. 
muscular  routes.  Following the administration  of the serum by the 
two different  routes,  blood cultures were taken  at short intervals  in 
order to determine the rate of sterilization of the blood.  The graph of a 
single experiment  (Text-fig.  1) shows that the sterilizing effect at the 936  TYPE  I  PNEUMOCOCCUS  ANTISERA 
end of a  given time after serum administration by the intramuscular 
route is as great as that seen during the same time by the intravenous 
route.  This result was noted constantly in a number of experiments, 
the only exception being in cases with very severe bacteremias where 
the  reduction in  the  number of organisms following intramuscular 
dosage was not always as great as that following intravenous dosage. 
DISCUSSION 
Certain definite facts appear evident from an analysis of the fore- 
going data.  Thus it seems that while the extent of survival of animals 
receiving different preparations of antipneumococcus sera by the two 
routes,  the  intramuscular and  intravenous, varies according to  the 
preparation, the size of the injected dose and the initial height of the 
bacteremia  at  the  time  of  serum  administration,  nevertheless  it 
appears that these factors are independent of the route of adminis- 
tration,  for when animals  grouped  under these different heads,  e.g. 
size of dose,  time of treatment, etc., are considered collectively ac- 
cording to the route of dosage only, the total survival rate by the 
intramuscular route is found to be, with the exudate antiserum, nearly 
as high and at times even higher than the survival rate by the intra- 
venous route of treatment, while with the standard vaccine antiserum 
the intramuscular route appears to be less satisfactory. 
Furthermore, on considering the sterilizing effect of intramuscular 
doses of serum in individual rabbits, it is seen that despite the indirect 
route, the bacteremic level falls as rapidly in the few cases tested as by 
the  intravenous  route,  except  in  cases  where there is  very severe 
bacteremia. 
The practical application of this experimental evidence is obvious. 
If the same thing is true for the human case of lobar pneumonia with 
bacteremia as is true for dermal pneumonia in rabbits it would then 
appear unnecessary to  continue the present method of intravenous 
therapy, except in the severe cases of bacteremia, the intramuscular 
route being likely to be nearly as effective, besides having the addi- 
tional advantages of convenience and being less  liable to untoward 
results.  If this is found to be true in human beings,  and evidence 
at present being accumulated points Strongly to that possibility, then 
the  use  of  intramuscular therapy in  pneumonia  should  make  the THEODORE  J.  CURPHEY  AND  HERMAN  B.  BARUCH  937 
serum treatment of the disease more popular in the hands of the gen- 
eral practitioner than it has been in the past. 
CONCLUSIONS 
1.  Intramuscular dosage of antipneumococcus sera in  a  standard 
dermal pneumococcic infection in rabbits is as effective as intravenous 
dosage provided the degree of blood stream invasion be not unusually 
high. 
2.  The immediate bactericidal effect of doses of serum given intra- 
muscularly is equal to that of the same doses given intravenously in 
the cases of mild and moderately severe bacteremias. 
3.  The intramuscular method of serum administration in human be- 
ings with lobar pneumonia deserves a  carefully controlled clinical trial. 
The authors hereby acknowledge their indebtedness to Dr. Arthur 
Washburn at whose suggestion the investigation was undertaken. 